Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSurgical Corporation was a private U.S. medical device company focused on surgical and wound-care delivery devices rather than therapeutics. Public records and FDA device clearances indicate it developed products including a multi-chamber suction syringe for wound treatment and technology for applying fibrin sealants in surgery. Historical executive biographies state the company developed a novel applicator for fibrin sealant and was acquired by Baxter around 2000. The company appears to have operated commercially as a medtech manufacturer and is no longer active as an independent entity following acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSurgical Corporation.